Skip to main content

Austrian Institute of Technology to Use Arrayit Platform

NEW YORK (GenomeWeb News) – The Austrian Institute of Technology will use Arrayit's Microarray Platform in its microbial diagnostics programs aimed at medical, environmental, and food safety testing, the company said today.

With nine locations in Austria, AIT conducts microarray, genotyping, gene expression, DNA methylation, and antibody and protein microarray research.

AIT also plans to develop system-integrated bio and nanosensors to improve medical diagnostics and therapies, for food safety control, and for environmental uses, the company said.

Financial terms of the agreement were not released.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.